• A “biomarker and translational research process & capabilities map” of the current capabilities of service providers in China, aligned to the critical stages of safety and efficacy biomarker and translational research activities
• A survey of leading China-based biomarker and translational service providers, medical centers, biobanks, and animal husbandry facilities, with assessment criteria defined by the project steering committee to ensure relevance
• A comprehensive review of current and emerging Chinese regulations governing the collection, use, and export of human biological samples, including direct dialogue with Chinese regulatory authorities
• A series of on-site visits—organized and led by CHA—to the most capable of the surveyed biomarker and translational research facilities, enabling clients to conduct a hands-on, collaborative, peer-driven assessment of these facilities, their management, and personnel
• A CHA-facilitated post-visit debrief of client perceptions and conclusions to promote the collaborative sharing of experience and insight among project participants
• A final report encapsulating the key findings of the biomarker and translational research process & capabilities map, the biomarker service providers survey, the on-site visits, and the client debrief

  Download full Project Description                                         Contact Us           

Previous Page    Back to Project Description    Next Page